Korean Journal of Pediatrics (Oct 2010)

A case of intracranial hemorrhage in a neonate with congenital factor VII deficiency

  • Won Seok Lee,
  • Young Sil Park

DOI
https://doi.org/10.3345/kjp.2010.53.10.913
Journal volume & issue
Vol. 53, no. 10
pp. 913 – 916

Abstract

Read online

Congenital factor VII deficiency is a rare autosomal-recessive bleeding disorder. Bleeding manifestations and clinical findings vary widely, ranging from asymptomatic subjects to patients with hemorrhages that may cause significant handicaps. Treatment has traditionally involved factor VII(FVII) replacement therapy using fresh frozen plasma, prothrombin complex concentrates or plasma-derived FVII concentrates. Recombinant activated FVII (NovoSeven®) is currently considered the first-line treatment for replacement therapy of FVII deficiency. Here we present a case of severe intracerebral and intraventricular hemorrhage in a neonate with congenital FVII deficiency.

Keywords